|
|
Volumn 40, Issue 11, 1997, Pages 1278-1285
|
|
Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations
a
|
|
Author keywords
amylin; HbA1c; IDDM; plasma glucose; Pramlintide; serum fructosamine
|
|
Indexed keywords
AMYLIN DERIVATIVE;
FRUCTOSAMINE;
GLUCOSE;
PRAMLINTIDE;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
BLOOD GLUCOSE MONITORING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
DRUG TOLERABILITY;
FEMALE;
HEADACHE AND FACIAL PAIN;
HUMAN;
HYPOGLYCEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
MAJOR CLINICAL STUDY;
MALE;
NAUSEA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SUBCUTANEOUS DRUG ADMINISTRATION;
VOMITING;
ADOLESCENT;
ADULT;
AMYLOID;
BLOOD GLUCOSE;
DIABETES MELLITUS, TYPE 1;
DOUBLE-BLIND METHOD;
FEMALE;
FRUCTOSAMINE;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MIDDLE AGED;
TREATMENT OUTCOME;
|
|
EID: 0030774171
PISSN: 0012186X
EISSN: 14320428
Source Type: Journal
DOI: 10.1007/s001250050821 Document Type: Article |
|
Times cited : (44)
|
|
References (19)
|
